General MedicationsORALStandard
OSELTAMIVIR PHOSPHATE
OSELTAMIVIR PHOSPHATE
Standard Dose
EQ 6MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OSELTAMIVIR PHOSPHATE is listed in Drugs@FDA under application 218131 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient OSELTAMIVIR PHOSPHATE Form and strength FOR SUSPENSION;ORAL - EQ 6MG BASE/ML Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2024-05-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview OSELTAMIVIR PHOSPHATE is listed in Drugs@FDA under application 218131 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient OSELTAMIVIR PHOSPHATE Form and strength FOR SUSPENSION;ORAL - EQ 6MG BASE/ML Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2024-05-10 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.